Published in Br Med J on August 21, 1976
The care of oral contraceptive users by general practitioners in Oxfordshire. J R Coll Gen Pract (1977) 2.14
Validity of anecdotal reports of suspected adverse drug reactions: the problem of false alarms. Br Med J (Clin Res Ed) (1982) 2.00
Ethnic group comparisons of variables associated with ischaemic heart disease. Br Heart J (1978) 1.63
Identification of adverse reactions to new drugs. II (continued): How were 18 important adverse reactions discovered and with what delays? Br Med J (Clin Res Ed) (1983) 1.24
Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London. Br Med J (1977) 1.18
Trends in the content and use of oral contraceptives in the United States, 1964-88. Am J Public Health (1991) 1.09
Benefits and risks of third-generation oral contraceptives. J Gen Intern Med (1999) 0.79
[Desogestrel contraceptives: the perfect pill for lipids?]. Can Fam Physician (1996) 0.75
The case-control study and retrospective controls. Br Med J (1979) 0.75
Adverse reactions to drugs. Br Med J (Clin Res Ed) (1983) 0.75
Estimation of relative risk from individually matched series. Biometrics (1970) 6.47
Oral contraceptives and death from myocardial infarction. Br Med J (1975) 3.12
Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol (1975) 1.78
Effectiveness and risks of birth-control methods. Br Med Bull (1970) 1.29
Editorial: Hormone use to change normal physiology - is the risk worth it? N Engl J Med (1976) 1.19
Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet (1969) 12.03
Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age. Br Med J (1968) 11.26
Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet (1992) 7.04
Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J (1970) 6.82
Interventions for promoting physical activity. Cochrane Database Syst Rev (2005) 5.83
Prescribing exercise in general practice. BMJ (1994) 4.73
Role of drug-reaction monitoring in the investigation of thrombosis and "the pill". Br Med Bull (1970) 4.37
Strategies for reducing coronary risk factors in primary care: which is most cost effective? BMJ (1995) 4.36
Cost-effectiveness of a primary care based physical activity intervention in 45-74 year old men and women: a randomised controlled trial. Br J Sports Med (1998) 4.23
Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chronic Dis (1975) 4.17
Guidelines for detection and management of dyslipidaemia. Scientific Committee of the National Heart Foundation of New Zealand. N Z Med J (1993) 3.18
Oral contraceptives and death from myocardial infarction. Br Med J (1975) 3.12
Lack of willpower or lack of wherewithal? "Internal" and "external" barriers to changing diet and exercise in a three year follow-up of participants in a health check. Soc Sci Med (1998) 3.10
Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J (Clin Res Ed) (1981) 3.08
Diagnosing insulin resistance in the general population. Diabetes Care (2001) 3.06
Randomised controlled trials of physical activity promotion in free living populations: a review. J Epidemiol Community Health (1995) 2.91
A community study of diabetes in Oxfordshire. J R Coll Gen Pract (1983) 2.88
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Comparison of high-fat and high-protein diets with a high-carbohydrate diet in insulin-resistant obese women. Diabetologia (2004) 2.66
Lifestyle advice in general practice: rates recalled by patients. BMJ (1992) 2.64
A systematic review of physical activity promotion strategies. Br J Sports Med (1996) 2.63
Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ (1996) 2.61
Costs and cost effectiveness of health checks conducted by nurses in primary care: the Oxcheck study. BMJ (1996) 2.58
Jaundice after repeated exposure to halothane: an analysis of Reports to the Committee on Safety of Medicines. Br Med J (1974) 2.56
Symptomless diverticular disease and intake of dietary fibre. Lancet (1979) 2.45
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
A high carbohydrate leguminous fibre diet improves all aspects of diabetic control. Lancet (1981) 2.35
The carrot, the stick and the general practitioner: how have changes in financial incentives affected health promotion activity in general practice? Br J Gen Pract (1995) 2.29
Maternal drug histories and congenital abnormalities. Br Med J (1977) 2.22
Health promotion in primary care. BMJ (1996) 2.22
Prevalence of stroke survivors in rural South Africa: results from the Southern Africa Stroke Prevention Initiative (SASPI) Agincourt field site. Stroke (2004) 2.22
The care of oral contraceptive users by general practitioners in Oxfordshire. J R Coll Gen Pract (1977) 2.14
Clinical profile of angioedema associated with angiotensin converting-enzyme inhibition. JAMA (1988) 2.13
Epidemiology of type 1 (insulin-dependent) diabetes in Scotland 1968-1976: evidence of an increasing incidence. Diabetologia (1983) 2.12
Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health (1997) 2.08
Study of fatal bone marrow depression with special reference to phenylbutazone and oxyphenbutazone. Br Med J (1977) 2.08
Cardiovascular risk and attitudes to lifestyle: what do patients think? BMJ (1993) 2.07
Lipid screening: is it enough to measure total cholesterol concentration? BMJ (1990) 2.06
The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabet Med (1988) 2.03
Preliminary trial of the effect of general practice based nutritional advice. Br J Gen Pract (1990) 2.02
Risk factors for myocardial infarction in young women. Br J Prev Soc Med (1976) 2.01
An investigation of risk factors for symptomatic osteoarthritis of the knee in women using a life course approach. J Epidemiol Community Health (2003) 1.99
Desire for the body normal: body image and discrepancies between self reported and measured height and weight in a British population. J Epidemiol Community Health (1996) 1.96
Reducing the risks of coronary heart disease in individuals and in the population. Lancet (1986) 1.95
Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain. Br Med J (Clin Res Ed) (1987) 1.91
Dietary determinants of ischaemic heart disease in health conscious individuals. Heart (1997) 1.87
Triglyceride fatty acids confirm a change in dietary fat. Clin Endocrinol (Oxf) (1977) 1.86
Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Health Technol Assess (2000) 1.80
Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J (1975) 1.79
Attitudes to adverse drug reaction reporting. Br J Clin Pharmacol (1996) 1.78
Cereal grains, legumes and diabetes. Eur J Clin Nutr (2004) 1.77
Randomised trial of lipid lowering dietary advice in general practice: the effects on serum lipids, lipoproteins, and antioxidants. BMJ (1995) 1.75
The Oxford Vegetarian Study: an overview. Am J Clin Nutr (1999) 1.75
Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev (2007) 1.71
Death from ischaemic heart disease. Br Med J (1977) 1.70
Oral contraceptives and fatal subarachnoid haemorrhage. Br Med J (1979) 1.69
Pragmatic randomized trial of home visits by a nurse to elderly people with hypertension in Mexico. Int J Epidemiol (2001) 1.68
Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trélat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med (1987) 1.66
Speculations about mortality trends from venous thromboembolic disease in England and Wales and their relation to the pattern of oral contraceptive usage. J Obstet Gynaecol Br Commonw (1973) 1.66
Improved glucose control in maturity-onset diabetes treated with high-carbohydrate-modified fat diet. Br Med J (1979) 1.65
Evaluation of spontaneous reports of adverse reactions to drugs. Br Med J (1972) 1.64
Eating disorders in young adults with insulin dependent diabetes mellitus: a controlled study. BMJ (1991) 1.62
Postmarketing surveillance of adverse drug reactions in general practice. I: search for new methods. Br Med J (Clin Res Ed) (1981) 1.59
Prescription-event monitoring of 10,401 patients treated with fluvoxamine. Br J Psychiatry (1994) 1.58
Diabetes in the elderly: the Oxford Community Diabetes Study. Diabet Med (1989) 1.54
Dietary fibre: an agreed definition. Lancet (2009) 1.54
Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev (2005) 1.53
Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes (1982) 1.53
Fibre and bowel transit times. Br J Nutr (1981) 1.51
Enalapril-induced cough. Lancet (1986) 1.51
Impaired glucose tolerance and NIDDM: does a lifestyle intervention program have an effect? Diabetes Care (1994) 1.50
Geographical variation in the incidence of diabetes mellitus in Scottish children during the period 1977-1983. Diabet Med (1988) 1.49
The type and quality of randomized controlled trials (RCTs) published in UK public health journals. J Public Health Med (1995) 1.46
Jaundice after repeated exposure to halothane: a further analysis of reports to the Committee on Safety of Medicines. Br Med J (1978) 1.45
A family study of the association between insulin dependent diabetes mellitus, autoantibodies and the HLA system. Tissue Antigens (1984) 1.44
Determination of the glycaemic index of foods: interlaboratory study. Eur J Clin Nutr (2003) 1.41
Diabetes--inpatient utilisation, costs and data validity. Dunedin 1985-9. N Z Med J (1992) 1.39
Fatal subarachnoid haemorrhage in young women: role of oral contraceptives. Br Med J (Clin Res Ed) (1981) 1.38
A randomised controlled trial of feedback to general practitioners of their prophylactic aspirin prescribing. BMJ (1997) 1.38
Myocardial infarction and oral contraceptives, a retrospective case control study in England and Scotland ('MICA' Study). Pharmacoepidemiol Drug Saf (1997) 1.37
Oral contraceptives and myocardial infarction: results of the MICA case-control study. BMJ (1999) 1.35
Hypertriglyceridaemia and hypercoagulability. Lancet (1983) 1.34
A randomized controlled trial of low carbohydrate and low fat/high fiber diets for weight loss. Am J Public Health (1986) 1.33
Oral contraception and myocardial infarction revisited: the effects of new preparations and prescribing patterns. Br J Obstet Gynaecol (1981) 1.33
Intermittent claudication: factors determining outcome. Br Med J (1978) 1.33
Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. Br J Nutr (1978) 1.32
Serum lipids in young female survivors of myocardial infarction. Br Heart J (1975) 1.31